Action Active Biotech Ab - 0GQU

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

2,85

Prix Achat

0,00

Prix Vente

0,00

Volume échangé

0,00

0,00 Fourchette du Jour 0,00

2,85 Plage de 52 semaines 2,85

Cap du marché

1,031B

Clôture Veille

2,85

Ouverture

Dernière Transaction

(O)

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

14 306

Actions en circulation

361 739 000

Rendement du Dividende

Ratio Cours sur Bénéfices

-22,51

Bénéfice par action (BPA)

-0,13

Chiffre d'affairess

Bénéfice net

-45,8M

Secteur

Pharmaceutical Preparations

Industrie

Pharmaceutical Diversified

Site Web

www.activebiotech.com

Siège social

Lund, Swe

Fondé

1994

Active Biotech Ab est coté dans le secteur Pharmaceutical Preparations de la London Stock Exchange avec le ticker 0GQU. Le dernier cours de clôture d'Active Biotech Ab était de SEK2,85. Au cours de la dernière année, les actions de Active Biotech Ab ont été négociées dans une fourchette de prix de SEK 2,85 à SEK 2,85.

Active Biotech Ab compte actuellement 361 739 000 actions en circulation. La capitalisation boursière d'Active Biotech Ab est de SEK1,03 milliard. Active Biotech Ab a un ratio cours/bénéfice (ratio PE) de -22.51.

Successful completion of the first stage of the phase IIa clinical trial of naptumomab in combination with docetaxel and the study is now enrolling into the second stage

Successful completion of the first stage of the phase IIa clinical trial of naptumomab in combination with docetaxel and the study is now...

Période	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	2.85	2.85	2.85	4000	2.85	DE
4	2.85	2.85	2.85	1491	2.85	DE
12	2.85	2.85	2.85	14306	2.85	DE
26	2.85	2.85	2.85	6444	2.85	DE
52	2.85	2.85	2.85	3237	2.85	DE
156	2.85	2.85	2.85	1456	2.85	DE
260	2.85	2.85	2.85	1253	2.85	DE

0GQU - Frequently Asked Questions (FAQ)

What is the current Active Biotech Ab share price?

The current share price of Active Biotech Ab is SEK 2,85

How many Active Biotech Ab shares are in issue?

Active Biotech Ab has 361 739 000 shares in issue

What is the market cap of Active Biotech Ab?

The market capitalisation of Active Biotech Ab is SEK 1,03B

What is the 1 year trading range for Active Biotech Ab share price?

Active Biotech Ab has traded in the range of SEK 2,85 to SEK 2,85 during the past year

What is the PE ratio of Active Biotech Ab?

The price to earnings ratio of Active Biotech Ab is -22,51

What is the reporting currency for Active Biotech Ab?

Active Biotech Ab reports financial results in SEK

What is the latest annual profit for Active Biotech Ab?

The latest annual profit of Active Biotech Ab is SEK -45,8M

What is the registered address of Active Biotech Ab?

The registered address for Active Biotech Ab is SCHEELEVAGEN 22, LUND, SE-223 63

What is the Active Biotech Ab website address?

The website address for Active Biotech Ab is www.activebiotech.com

Which industry sector does Active Biotech Ab operate in?

Active Biotech Ab operates in the PHARMACEUTICAL DIVERSIFIED sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
TUNTungsten West Plc	5,25p (55,56%)	5,82M
SIVSivota Plc	4,50p (50,00%)	10k
MATDPetro Matad Limited	2,225p (48,33%)	39,09M
MET1Metals One Plc	0,725p (26,09%)	10,06M
SAVESavannah Energy Plc	11,90p (19,60%)	12,27M
PR1Pri0r1ty Intelligence Group Plc	4,00p (-27,27%)	420k
NTQEnteq Technologies Plc	1,70p (-17,07%)	1,03M
FCMFirst Class Metals Plc	1,55p (-16,22%)	1,94M
BVCBatm Advanced Communications Ld	14,55p (-15,65%)	1,27M
AFRNAferian Plc	3,00p (-14,29%)	69,34k
VELAVela Technologies Plc	0,0027p (-6,90%)	501,87M
MSMNMosman Oil And Gas Limited	0,034p (13,33%)	432,08M
PREMPremier African Minerals Limited	0,021p (7,69%)	301,55M
LLOYLloyds Banking Group Plc	73,24p (2,55%)	295,3M
VRSVersarien Plc	0,028p (-12,50%)	256,45M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Active Biotech Ab (0GQU)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Active Biotech Ab

0GQU Dernières nouvelles

Successful completion of the first stage of the phase IIa clinical trial of naptumomab in combination with docetaxel and the study is now enrolling into the second stage

Annual General Meeting of Active Biotech AB

FDA grants Orphan Drug Designation for tasquinimod in myelofibrosis

Annual Report 2021 Active Biotech AB (publ)

Active Biotech strengthens the patent protection for laquinimod in eye disorders

Active Biotech Interim Report Q1 2022

Active Biotech: NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS

Number of shares and votes in Active Biotech

Correction: Active Biotech Year End Report 2021

Active Biotech: Year End Report 2021

0GQU - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Active Biotech Ab (0GQU) Cours

Active Biotech Ab (0GQU)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Active Biotech Ab

0GQU Dernières nouvelles

Successful completion of the first stage of the phase IIa clinical trial of naptumomab in combination with docetaxel and the study is now enrolling into the second stage

Annual General Meeting of Active Biotech AB

FDA grants Orphan Drug Designation for tasquinimod in myelofibrosis

Annual Report 2021 Active Biotech AB (publ)

Active Biotech strengthens the patent protection for laquinimod in eye disorders

Active Biotech Interim Report Q1 2022

Active Biotech: NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS

Number of shares and votes in Active Biotech

Correction: Active Biotech Year End Report 2021

Active Biotech: Year End Report 2021

0GQU - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités